Oakcliff Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GoodRx Holdings
GDRX
|
+$11.9M |
| 2 |
Cardlytics
CDLX
|
+$2.54M |
| 3 |
Guidewire Software
GWRE
|
+$1.19K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$6.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 40.3% |
| 2 | Industrials | 16.19% |
| 3 | Technology | 12.89% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 9.5% |
Similar funds
Oakcliff Capital Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Oakcliff Capital Partners held 11 positions worth $219M, down 3.1% from $226M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Oakcliff Capital Partners deployed $7.65M of net new capital in Q4 2021, opening 1 new position and adding to 2 existing holdings. Its largest new stake was GoodRx Holdings: 296,233 shares worth $9.68M.
By sector, the portfolio is most concentrated in Communication Services at 40% of assets, down from 45% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Charter Communications, an estimated $6.81M trimmed.
- Oakcliff Capital Partners's largest Q4 2021 buy was GoodRx Holdings: 296,233 shares worth $9.68M.
- Oakcliff Capital Partners added most to Cardlytics in Q4 2021, an estimated $2.54M increase.
- Oakcliff Capital Partners's biggest Q4 2021 reduction was Charter Communications, cutting an estimated $6.81M.
- Oakcliff Capital Partners's ten largest holdings make up 99% of its $219M portfolio in Q4 2021.
- Oakcliff Capital Partners opened 1 new position and closed 0 in Q4 2021.
- Oakcliff Capital Partners's portfolio value fell 3.1% quarter-over-quarter to $219M.
Based on Oakcliff Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.